Landscapes / Targets
GPC3
19 drugs act on GPC3, in 22 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs19
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 31 Mar 2027Phase 1/2 trial completes | |||
| Next date | 31 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma, Liver Cancer and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2027Phase 1/2 trial completes | |||
| Next date | Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1/2 | 30 Jun 2027Phase 1/2 trial completes | ||
| Next date | 30 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1/2 | 13 Dec 2027Phase 1/2 trial completes | ||
| Next date | 13 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma, Liver Cancer, Adult and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2028Phase 2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma (HCC) | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Apr 2030Phase 1/2 trial completes | |||
| Next date | 30 Apr 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma, Squamous Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jun 2030Phase 1/2 trial completes | |||
| Next date | Jun 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma (HCC) | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Hepatocellular Carcinoma, Squamous Cell Carcinoma of the Lung and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | HCC | ||||
| Open drug page | |||||
— |
Phase 1 | Aug 2027Phase 1 trial completes | |||
| Next date | Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignancies | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2027Phase 1 trial completes | |||
| Next date | Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma, Squamous Cell Non-Small Cell Lung Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Neoplasms, Carcinoma, Hepatocellular and 2 more | ||||
| Open drug page | |||||
— |
CREATE Medicines · Private |
Phase 1 | 31 Dec 2027Phase 1 trial completes | ||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Apr 2028Phase 1 trial completes | |||
| Next date | 30 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Hepatocellular Carcinoma (HCC) | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Jul 2029Phase 1 trial completes | |||
| Next date | 31 Jul 2029 · Phase 1 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma | ||||
| Open drug page | |||||
— |
Phase 1 | May 2030Phase 1 trial completes | |||
| Next date | May 2030 · Phase 1 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Metastatic and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 19 of 19 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026